{"id":"NCT01424670","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of Delamanid (OPC-67683) Administered Orally as 200 mg Total Daily Dose for Six Months in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-02","primaryCompletion":"2016-07-04","completion":"2016-07-04","firstPosted":"2011-08-29","resultsPosted":"2019-05-15","lastUpdate":"2019-05-15"},"enrollment":511,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Multidrug-resistant Tuberculosis"],"interventions":[{"type":"DRUG","name":"Delamanid + OBR","otherNames":[]},{"type":"DRUG","name":"Placebo + OBR","otherNames":[]}],"arms":[{"label":"Delamanid + OBR","type":"EXPERIMENTAL"},{"label":"Placebo + OBR","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to determine whether delamanid is effective in the treatment of multidrug-resistant tuberculosis (MDR TB) in combination with other MDR TB medications during 6 months of treatment.","primaryOutcome":{"measure":"Time To Sputum Culture Conversion (SCC) During 6-Month Intensive Period Using The Mycobacteria Growth Indicator Tube (MGIT) System","timeFrame":"Month 6","effectByArm":[{"arm":"Delamanid + OBR","deltaMin":51,"sd":null},{"arm":"Placebo + OBR","deltaMin":57,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0562"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":17,"countries":["Estonia","Latvia","Lithuania","Moldova","Peru","Philippines","South Africa"]},"refs":{"pmids":["30630778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":89,"n":341},"commonTop":["Arthralgia","Nausea","Headache","Insomnia","Vomiting"]}}